Sarcopenia in breast cancer: prognostic values and emerging therapeutic strategies - Top-Institutions - MDSpire

Sarcopenia in breast cancer: prognostic values and emerging therapeutic strategies

  • By

  • Bo Xiang

  • Dongyi Zhao

  • Tao Liu

  • Guiying Xu

  • July 15, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Erasmus MC
    Erasmus MC

    Rotterdam, Netherlands

    Key Differentiators

    • Oncology

  • #3

    University of Chicago Hospital
    University of Chicago Hospital

    Chicago, Illinois

    Key Differentiators

    • Oncology

  • #4

    Sbarro Health Research Organization
    Sbarro Health Research Organization

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology

  • #5

    Temple University
    Temple University

    Philadelphia, Pennsylvania

    Key Differentiators

    • Oncology

Original Source(s)

Sarcopenia in breast cancer: prognostic values and emerging therapeutic strategies

  • by Bo Xiang, Dongyi Zhao, Tao Liu, Guiying Xu

  • July 15, 2026

Related Content

Immunological barriers and engineering strategies for CAR-T cell therapy in acute myeloid leukemia

Helicobacter pylori infection in gastric cancer patients in French Guiana: a hospital-based study (2018–2023)

Galectins at the crossroads of tumor immunity, metabolism, and metastasis: mechanisms, therapeutic resistance, and translational opportunities